Top Markets
#1 Prom Prom +36.01%
#2 QuantixAI QuantixAI +31.15%
#3 MowCat MowCat +29.66%
#4 UnifAI Network UnifAI Network +28.77%
#5 GEKKO GEKKO +24.99%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +21.66%
#7 DOG•GO•TO•THE•MOON (Runes) DOG•GO•TO•THE•MOON (Runes) +20.29%
#8 MarsCoin MarsCoin +19.40%
#9 Kinesis Silver Kinesis Silver +18.57%
#10 Versatize Coin Versatize Coin +16.66%
Coin of the day
Prom Prom
Settings
Language
ENGLISH
Currency
USD
Theme
Tien Liang BioTech Co., Ltd. Tien Liang BioTech Co., Ltd.

Tien Liang BioTech Co., Ltd.

4127
Rank in Stocks #20701
Tien Liang BioTech Co., Ltd., established in 1960 and headquartered in New... Tien Liang BioTech Co., Ltd., established in 1960 and headquartered in New Taipei City, Taiwan, is a pharmaceutical enterprise involved in the development, manufacturing, and global distribution of a diverse array of health and medicinal products. The company's offerings include traditional Chinese medicine (TCM) formulations, predominantly in pill form. These remedies address a broad spectrum of conditions, such as internal organ deficiencies (e.g., liver and kidney), various forms of musculoskeletal and neuropathic discomfort (including low back pain, joint pain, rheumatism, gout, and neuralgia), and common ailments like dizziness, digestive issues (constipation, hemorrhoids), respiratory symptoms (colds, bronchitis, coughs), and skin conditions (athlete's foot). Additionally, Tien Liang BioTech provides a range of Western pharmaceutical products. This segment features topical applications like ointments, pain relief gels, soreness sprays, and transdermal pain patches, alongside oral preparations such as tablets and capsules. The portfolio also includes specialized items like hair removal creams. Beyond pharmaceuticals, the company extends its reach into general consumer health and personal care. These offerings comprise products designed for body relaxation and comfort, items to alleviate post-exercise discomfort, oral hygiene products, and various soaps.
Share Price
$2.71
Market Cap
$124.12M
Change (1 day)
-3.62%
Change (1 year)
138.18%
Country
TW
Trade Tien Liang BioTech Co., Ltd. (4127)

Category

Healthcare
Operating Margin for Tien Liang BioTech Co., Ltd. (4127)
Operating Margin as of 2026 TTM: 0.00%
According to Tien Liang BioTech Co., Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Tien Liang BioTech Co., Ltd. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
0.00% -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
0.00% -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
0.00% -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
0.00% -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
22.93% -
IN
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.